Methods in Bone Biology: Cancer and Bone

  • Yu Zheng
  • Markus J. Seibel
  • Hong ZhouEmail author


Metastasis of cancer to bone is one of the most significant causes of morbidity and often indicates poor prognosis particularly for breast cancer, prostate cancer, and lung cancer patients. Animal models are important tools to investigate the pathogenesis of, and develop novel treatment strategies for, bone metastases in humans. The ideal animal model of bone metastatic human cancer would reproduce the genetic and phenotypic changes that occur with human cancers.


Bone Metastasis Bone Microenvironment Contralateral Tibia Ideal Animal Model Phosphate Buffer Saline Control 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors would like to thank Dr Marcus Neudert and Professor Frieder Bauss, Germany, for their assistance with the description of the intra-arterial rat model. This work has been supported by the following research grants: Prostate Cancer Foundation of Australia (PCFA) (M.J.S, Y.Z, H.Z), University of Sydney Cancer Research Fund (M.J.S), and National Health and Medical Research Council, Australia (NHMRC) (M.J.S, H.Z.). Y.Z receives support from the National Health & Medical Research Council Australia, Training Fellowship.


  1.  1.
    Rosol TJ, Tannehill-Gregg SH, Corn S, Schneider A, McCauley LK. Animal models of bone metastasis. Cancer Treat Res. 2004;118:47-81.PubMedGoogle Scholar
  2.  2.
    Zheng Y, Zhou H, Brennan K, et al. Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis. Bone. 2007;40:471-478.PubMedCrossRefGoogle Scholar
  3.  3.
    Zheng Y, Zhou H, Fong-Yee C, Modzelewski JR, Seibel MJ, Dunstan CR. Bone resorption increases tumour growth in a mouse model of osteosclerotic breast cancer metastasis. Clin Exp Metastasis. 2008;25:559-567.PubMedCrossRefGoogle Scholar
  4.  4.
    Zheng Y, Zhou H, Modzelewski JR, et al. Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. Cancer Res. 2007; 67:9542-9548.PubMedCrossRefGoogle Scholar
  5.  5.
    Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res. 2001;16:1486-1495.PubMedCrossRefGoogle Scholar
  6.  6.
    Neudert M, Fischer C, Krempien B, Bauss F, Seibel MJ. Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth. Int J Cancer. 2003;107:468-477.PubMedCrossRefGoogle Scholar
  7.  7.
    Mehta RR, Graves JM, Hart GD, Shilkaitis A, Das Gupta TK. Growth and metastasis of human breast carcinomas with Matrigel in athymic mice. Breast Cancer Res Treat. 1993;25:65-71.PubMedCrossRefGoogle Scholar
  8.  8.
    Ooi LL, Zhou H, Kalak R, et al. Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. Cancer Res. 2010;70:1835-1844.PubMedCrossRefGoogle Scholar
  9.  9.
    Ooi LL, Zheng Y, Zhou H, et al. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis. Bone. 2010;47:795-803.PubMedCrossRefGoogle Scholar
  10. 10.
    Zheng Y, Zhou H, Ooi LL, et al. Vitamin D deficiency ­promotes prostate cancer growth in bone. Prostate. 2011 Jun 15;71(9):1012-21..Google Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  1. 1.Bone Research Program, ANZAC Research InstituteUniversity of SydneyConcordAustralia

Personalised recommendations